Literature DB >> 25820714

Urinary pellet sample preparation for shotgun proteomic analysis of microbial infection and host-pathogen interactions.

Yanbao Yu1, Rembert Pieper.   

Abstract

Urine is one of the most important biofluids in clinical proteomics, and in the past decades many potential disease biomarkers have been identified using mass spectrometry-based proteomics. Current studies mainly perform analyses of the urine supernatant devoid of cells and cell debris, and the pellet (or sediment) fraction is discarded. However, the pellet fraction is biologically of interest. It may contain whole human cells shed into the urine from anatomically proximal tissues and organs (e.g., kidney, prostate, bladder, urothelium, and genitals), disintegrated cells and cell aggregates derived from such tissues, viruses and microbial organisms which colonize or infect the urogenital tract. Knowledge of the function, abundance, and tissue of origin of such proteins can explain a pathological process, identify a microbe as the cause of urinary tract infection, and measure the human immune response to the infection-associated pathogen(s). Successful detection of microbial species in the urinary pellet via proteomics can serve as a clinical diagnostic alternative to traditional cell culture-based laboratory tests. Filter-aided sample preparation (FASP) has been widely used in shotgun proteomics. The methodology presented here implements an effective lysis of cells present in urinary pellets, solubilizes the majority of the proteins derived from microbial and human cells, and generates enzymatic digestion-compatible protein mixtures using FASP followed by optimized desalting procedures to provide a peptide fraction for sensitive and comprehensive LC-MS/MS analysis. A highly parallel sample preparation method in 96-well plates to allow scaling up such experiments is discussed as well. Separating peptides by nano-LC in one dimension followed by online MS/MS analysis on a Q-Exactive mass spectrometer, we have shown that more than 1,000 distinct microbial proteins and 1,000 distinct human proteins can be identified from a single experiment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25820714      PMCID: PMC6026852          DOI: 10.1007/978-1-4939-2550-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

2.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Urine in clinical proteomics.

Authors:  Stéphane Decramer; Anne Gonzalez de Peredo; Benjamin Breuil; Harald Mischak; Bernard Monsarrat; Jean-Loup Bascands; Joost P Schanstra
Journal:  Mol Cell Proteomics       Date:  2008-07-30       Impact factor: 5.911

Review 4.  Urine as a source for clinical proteome analysis: from discovery to clinical application.

Authors:  Eva Rodríguez-Suárez; Justyna Siwy; Petra Zürbig; Harald Mischak
Journal:  Biochim Biophys Acta       Date:  2013-07-02

Review 5.  Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.

Authors:  Steven L Wood; Margaret A Knowles; Douglas Thompson; Peter J Selby; Rosamonde E Banks
Journal:  Nat Rev Urol       Date:  2013-02-26       Impact factor: 14.432

Review 6.  The epidemiology of urinary tract infection.

Authors:  Betsy Foxman
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

7.  Proteomic workflow for analysis of archival formalin-fixed and paraffin-embedded clinical samples to a depth of 10 000 proteins.

Authors:  Jacek R Wiśniewski; Kamila Duś; Matthias Mann
Journal:  Proteomics Clin Appl       Date:  2013-03-06       Impact factor: 3.494

Review 8.  Urine proteomics: the present and future of measuring urinary protein components in disease.

Authors:  Jonathan Barratt; Peter Topham
Journal:  CMAJ       Date:  2007-08-14       Impact factor: 8.262

9.  Urine sample preparation in 96-well filter plates for quantitative clinical proteomics.

Authors:  Yanbao Yu; Moo-Jin Suh; Patricia Sikorski; Keehwan Kwon; Karen E Nelson; Rembert Pieper
Journal:  Anal Chem       Date:  2014-05-14       Impact factor: 6.986

10.  Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury.

Authors:  Derrick E Fouts; Rembert Pieper; Sebastian Szpakowski; Hans Pohl; Susan Knoblach; Moo-Jin Suh; Shih-Ting Huang; Inger Ljungberg; Bruce M Sprague; Sarah K Lucas; Manolito Torralba; Karen E Nelson; Suzanne L Groah
Journal:  J Transl Med       Date:  2012-08-28       Impact factor: 5.531

View more
  10 in total

1.  Quick 96FASP for high throughput quantitative proteome analysis.

Authors:  Yanbao Yu; Shiferaw Bekele; Rembert Pieper
Journal:  J Proteomics       Date:  2017-06-29       Impact factor: 4.044

2.  Influenza Causes MLKL-Driven Cardiac Proteome Remodeling During Convalescence.

Authors:  Yi-Han Lin; Maryann P Platt; Ryan P Gilley; David Brown; Peter H Dube; Yanbao Yu; Norberto Gonzalez-Juarbe
Journal:  Circ Res       Date:  2021-01-27       Impact factor: 17.367

3.  Comprehensive Metaproteomic Analyses of Urine in the Presence and Absence of Neutrophil-Associated Inflammation in the Urinary Tract.

Authors:  Yanbao Yu; Patricia Sikorski; Madeline Smith; Cynthia Bowman-Gholston; Nicolas Cacciabeve; Karen E Nelson; Rembert Pieper
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

4.  Type 1 Diabetes: Urinary Proteomics and Protein Network Analysis Support Perturbation of Lysosomal Function.

Authors:  Harinder Singh; Yanbao Yu; Moo-Jin Suh; Manolito G Torralba; Robert D Stenzel; Andrey Tovchigrechko; Vishal Thovarai; Derek M Harkins; Seesandra V Rajagopala; Whitney Osborne; Fran R Cogen; Paul B Kaplowitz; Karen E Nelson; Ramana Madupu; Rembert Pieper
Journal:  Theranostics       Date:  2017-07-07       Impact factor: 11.556

Review 5.  Proteomics progresses in microbial physiology and clinical antimicrobial therapy.

Authors:  B Chen; D Zhang; X Wang; W Ma; S Deng; P Zhang; H Zhu; N Xu; S Liang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

6.  Characterization of Early-Phase Neutrophil Extracellular Traps in Urinary Tract Infections.

Authors:  Yanbao Yu; Keehwan Kwon; Tamara Tsitrin; Shiferaw Bekele; Patricia Sikorski; Karen E Nelson; Rembert Pieper
Journal:  PLoS Pathog       Date:  2017-01-27       Impact factor: 6.823

7.  Direct Identification of Urinary Tract Pathogens by MALDI-TOF/TOF Analysis and De Novo Peptide Sequencing.

Authors:  Ema Svetličić; Lucija Dončević; Luka Ozdanovac; Andrea Janeš; Tomislav Tustonić; Andrija Štajduhar; Antun Lovro Brkić; Marina Čeprnja; Mario Cindrić
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

8.  Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication.

Authors:  Christopher M Murphy; Yanping Xu; Feng Li; Kouki Nio; Natalia Reszka-Blanco; Xiaodong Li; Yaxu Wu; Yanbao Yu; Yue Xiong; Lishan Su
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

9.  Global Proteome and Phosphoproteome Characterization of Sepsis-induced Kidney Injury.

Authors:  Yi-Han Lin; Maryann P Platt; Haiyan Fu; Yuan Gui; Yanlin Wang; Norberto Gonzalez-Juarbe; Dong Zhou; Yanbao Yu
Journal:  Mol Cell Proteomics       Date:  2020-09-22       Impact factor: 7.381

Review 10.  The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness.

Authors:  Ciro Andolfi; Jeffrey C Bloodworth; Apostolos Papachristos; Randy F Sweis
Journal:  Bladder Cancer       Date:  2020-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.